The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Telomir Pharmaceuticals Inc (NASDAQ: TELO) closed the day trading at $1.64 up 2.50% from the previous closing price of $1.6. In other words, the price has increased by $2.50 from its previous closing price. On the day, 2.2 million shares were traded. TELO stock price reached its highest trading level at $1.75 during the session, while it also had its lowest trading level at $1.63.
Ratios:
For a better understanding of TELO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on February 21, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TELO now has a Market Capitalization of 55482788 and an Enterprise Value of 52279900.
Stock Price History:
The Beta on a monthly basis for TELO is -0.78, which has changed by -0.6653061 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, TELO has reached a high of $7.08, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is 11.41%, while the 200-Day Moving Average is calculated to be -38.85%.
Shares Statistics:
Over the past 3-months, TELO traded about 5.47M shares per day on average, while over the past 10 days, TELO traded about 7017340 shares per day. A total of 30.51M shares are outstanding, with a floating share count of 12.97M. Insiders hold about 59.82% of the company’s shares, while institutions hold 8.70% stake in the company. Shares short for TELO as of 1759190400 were 1314090 with a Short Ratio of 0.24, compared to 1756425600 on 3249510. Therefore, it implies a Short% of Shares Outstanding of 1314090 and a Short% of Float of 5.55.
Earnings Estimates
A detailed examination of Telomir Pharmaceuticals Inc (TELO) is currently in progress, with 1 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.38 and -$0.38 for the fiscal current year, implying an average EPS of -$0.38. EPS for the following year is -$0.28, with 1.0 analysts recommending between -$0.28 and -$0.28.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $1.5M in the next fiscal year. The high estimate is $1.5M and the low estimate is $1.5M.
